Internal Reference Number: FOI_8093
Date Request Received: 12/08/2024 00:00:00
Date Request Replied To: 27/08/2024 00:00:00
This response was sent via: By Email
Request Summary: Request on Asthma
Request Category: Researcher
| Question Number 1: How many patients have been treated (for any condition) in the last 4 months with: 鈥� Benralizumab 鈥� Dupilumab 鈥� Omalizumab 鈥� Reslizumab 鈥� Mepolizumab 鈥� Tezepelumab | |
| Answer To Question 1: Please see attached document with answers to Q1-3 To accompany this answer to question 1 please also see the documents listed below:  FOI 8093.pdf | |
| Question Number 2: Of the patients treated in the last 4 months with any of the above products, please provide the number of patients by the following age-groups: 鈥� Age 6-11 鈥� Age 12-17 鈥� Age 18 and above | |
| Answer To Question 2: Please see attached document with answers to Q1-3 | |
| Question Number 3: How many patients have been treated in the last 4 months by the Respiratory Medicine department ONLY with: 鈥� Dupilumab 鈥� Omalizumab | |
| Answer To Question 3: Please see attached document with answers to Q1-3 | |
| Please see Attachments: | |
| To return to the list of all the FOI requests please click here | |
Our staff at SA国际传媒 Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
